SINGAPORE, August 8 – Avantor, Inc. (NYSE: AVTR), a leading global provider of products and services in the life sciences, advanced technologies, and applied materials industries, marked a significant milestone with the inauguration of its expanded Singapore Hub. The facility now includes cGMP manufacturing capabilities and a world-class quality control laboratory, making it a comprehensive one-stop facility serving customers across Asia, Middle East, and Africa (AMEA). The expansion is expected to strengthen the region’s innovation and biopharma ecosystems.
Located strategically in Singapore, the expanded hub is designed to enhance operational efficiency and provide quicker turnaround times for customers. It facilitates easier access to essential raw materials for drug discovery and development in the AMEA region, while ensuring adherence to stringent quality standards. Christophe Couturier, Executive Vice President of AMEA at Avantor, highlighted the company’s commitment to meeting the evolving needs of customers in the biopharma industry. “At Avantor, we recognize the growing complexities around customer requirements and regulatory standards across AMEA’s biopharma industry.
By enhancing our regional capabilities through the launch of our Singapore Manufacturing and Distribution Hub, we tap into our legacy of serving the evolving needs of customers, demonstrating our commitment to advancing life-changing science.” The inauguration ceremony, attended by Avantor executives and representatives from the Singapore Economic Development Board (EDB), showcased the significance of Avantor’s investment in Singapore. The EDB, represented by Elaine Teo, Senior Vice President and Head of Investment Facilitation, emphasized the positive impact of Avantor’s expansion on the supply chain resilience for biopharma manufacturers in Singapore and the region.
The investments made by Avantor demonstrate confidence in Singapore’s manufacturing and supply chain capabilities, contributing to the growth and competitiveness of the biomedical sciences industry. The expanded Singapore Hub builds on Avantor’s previous investments and integrates the distribution hub with new manufacturing operations. The facility features cGMP suites, quality testing capabilities, certified product warehousing, batch-to-batch traceability, and customized palletization capabilities.
These state-of-the-art facilities enable Avantor to drive innovation and efficiency in addressing the immediate challenges faced by the biopharma industry in the AMEA region. Avantor’s expanded Singapore Hub will play a pivotal role in supporting the growth and development of the biopharma industry in AMEA. By providing comprehensive services and high-quality products, Avantor aims to accelerate advancements in life sciences and contribute to the success of customers in the region.
